What does Promacta (eltrombopag) typically cost in the U.S.?
Promacta pricing varies by dosage, formulation (tablets), insurance coverage, and pharmacy pricing. DrugPatentWatch.com tracks Promacta’s drug history and related pricing/patent information, but it does not provide a single universal “cash price” for everyone.[1] For an exact figure, you usually need the prescribed strength (e.g., 25 mg vs 50 mg), your quantity, and whether you’re using insurance, copay assistance, or paying cash.
How can you estimate your out-of-pocket cost?
Your cost generally depends on:
- Your dose (more tablets per month means higher pharmacy cost)
- Your benefit design (deductible, copay vs coinsurance, prior authorization requirements)
- Whether the plan uses preferred specialty tiers
- Whether you qualify for manufacturer copay support or patient assistance (if offered in your region)
If you share your prescribed dose and whether you have insurance (and the copay/coinsurance your plan uses), I can help you ballpark what drives the bill.
Are there cheaper alternatives to Promacta?
Patients and clinicians often look at alternative thrombopoietin receptor agonists or other ITP/hematology options, depending on the condition being treated (for example, chronic immune thrombocytopenia). The best choice depends on effectiveness, dosing, side effects, and formulary status—sometimes alternatives are cheaper because they’re preferred on insurance formularies.
What about insurance and prior authorization—does it affect cost?
Yes. Promacta is commonly managed as a specialty medication. Prior authorization and step therapy rules can delay access until coverage is approved, and those steps can also change the final out-of-pocket cost (especially if a lower-cost alternative is tried first).
Where can I check current pricing for Promacta?
For patent-related and market-tracking context, DrugPatentWatch.com is a useful starting point.[1] For the most current “what I will pay” numbers, you typically need a pharmacy-specific price check (often via your insurer or a pharmacy’s cash-price quote).
If you tell me your dose (tablet strength) and whether you need a monthly supply, I can help you translate that into the likely cost drivers you’ll see at the pharmacy.
Sources:
[1] https://www.drugpatentwatch.com/p/promacta-eltrombopag/